JNJ vs XBPEW · P/E 17, rev $49.37B vs rev $191.3M
Johnson & Johnson (JNJ) versus XBP Europe Holdings Inc (XBPEW) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
XBP Europe Holdings Inc (XBPEW) is a software - infrastructure company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported XBPEW revenue for 2026-06-30 was $191.3M. Net income was -$16.7M. Revenue was down 3.0% from 2026-03-31 to 2026-06-30. XBPEW currently screens at market cap $0.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. XBPEW currently screens at market cap $0.
Not investment advice. Open the JNJ and XBPEW stock pages for the full models.
Not investment advice.